Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1166.45
-9.10 (-0.77%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 19-05-2022
The March 2022 quarter revenue stood at Rs. 36687.00 millions, up 9.49% as compared to Rs. 33507.00 millions during the corresponding quarter last year.Good  Net Profit growth of 34.74% reported above the corresponding previous quarter figure of Rs. 3115.00 millions to Rs. 4197.00 millioins.Operating profit surged to 7846.00 millions from the corresponding previous quarter of 6845.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 36687.00 33507.00 9.49 144052.00 133491.00 7.91 144052.00 133491.00 7.91
Other Income 1147.00 816.00 40.56 4820.00 8011.00 -39.83 4820.00 8011.00 -39.83
PBIDT 7846.00 6845.00 14.62 30761.00 39379.00 -21.88 30761.00 39379.00 -21.88
Interest 127.00 169.00 -24.85 380.00 467.00 -18.63 380.00 467.00 -18.63
PBDT 7719.00 6676.00 15.62 30381.00 38912.00 -21.92 30381.00 38912.00 -21.92
Depreciation 2052.00 2107.00 -2.61 8143.00 8350.00 -2.48 8143.00 8350.00 -2.48
PBT 5667.00 4569.00 24.03 22238.00 30562.00 -27.24 22238.00 30562.00 -27.24
TAX 1470.00 1454.00 1.10 6006.00 8698.00 -30.95 6006.00 8698.00 -30.95
Deferred Tax 496.00 666.00 -25.53 2080.00 3297.00 -36.91 2080.00 3297.00 -36.91
PAT 4197.00 3115.00 34.74 16232.00 21864.00 -25.76 16232.00 21864.00 -25.76
Equity 832.00 832.00 0.00 832.00 832.00 0.00 832.00 832.00 0.00
PBIDTM(%) 21.39 20.43 4.69 21.35 29.50 -27.61 21.35 29.50 -27.61